British Ophthalmological Surveillance Unit obtains further funding

Article

Fight for Sight has given further funding to the British Ophthalmological Surveillance Unit (BOSU) for research into preventing sight loss and treating eye disease.

Fight for Sight has given further funding to the British Ophthalmological Surveillance Unit (BOSU) for research into preventing sight loss and treating eye disease.

BOSU provides ophthalmologists with a Reporting Card so they can alert researchers to uncommon eye disease cases. The data collected goes towards research projects investigating rare eye disorders.

Dr Rashmi Matthew, who used BOSU to develop the British Ocular Syphillis Study, said, "BOSU has been invaluable in furthering our understanding of ocular syphilis- a rare form of the sexually transmitted disease. Through the support of Fight for Sight and the Royal College of Ophthalmologists, many more researchers will benefit from this essential resource, expanding our knowledge of rare eye conditions and disorders.”

Chief Executive of Fight for Sight, said, “Ophthalmologists play a vital role in the identification and reporting of uncommon eye diseases, as well as rare complications of more common eye conditions, and their participation in BOSU has a huge impact on medical research into eye disease. Through our work with BOSU, we hope to inspire even more people to help raise awareness within the medical profession of the less common conditions under investigation.”

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.